Latest AI and machine learning research in oncology/hematology for healthcare professionals.
INTRODUCTION: Lung cancer (LC) is the leading cause of cancer-related mortality worldwide, primarily...
Early-stage infrared forest fire detection is severely hindered by strong background thermal interfe...
Molecular subtyping is essential for guiding systemic therapy in breast cancer but currently require...
PURPOSE: The prognostic significance of tumor-infiltrating lymphocytes (TILs) in colorectal cancer (...
Accurate classification of renal masses before treatment is crucial for therapeutic decision-making ...
AIM: To develop and validate a deep learning-based AI system for the dynamic, real-time differentiat...
BACKGROUND: Differentiating between spinal tuberculosis, pyogenic (bacterial) spondylitis and spinal...
Polygenic risk scores (PRS) have emerged as important tools for quantifying inherited susceptibility...
Traditional cell counting in clinical and research settings often relies on hemocytometry, a manual ...
BACKGROUND: Cancer therapy-related cardiac dysfunction (CTRCD) has become an important clinical issu...
INTRODUCTION: Hematoxylin & Eosin (H&E) stained slides are the gold standard for cancer diagnosis bu...
Tertiary lymphoid structures (TLSs) are key components of the tumor immune microenvironment and show...
The self-assembly of block copolymers (BCPs) in solution is a primary method for creating functional...
Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal human cancers, mostly due to ...
PURPOSE: To evaluate the feasibility and diagnostic performance of ultra-low-dose CT (ULD-CT) for sc...
Accurate brain tumor segmentation is essential for preoperative evaluation and personalized treatmen...
Immunotherapy has long played a pivotal role in cancer treatment, and antigen-presenting cell (APC)-...
Metabolic dysfunction-associated steatotic liver disease (MASLD) represents a leading global health ...
BACKGROUND: Deep learning methods have made great progress in the automatic segmentation of nasophar...
Identifying robust biomarkers for early cancer detection remains challenging, particularly when work...
PURPOSE: High-risk stage II colorectal cancer (CRC) shows heterogeneous outcomes despite adjuvant ch...